Registration

Register for SYLVANT® (siltuximab) Updates

Register for SYLVANT® (siltuximab) Updates

Registration

Healthcare professional opt-in

If you would like to receive Multicentric Castleman’s Disease (MCD) news and updates from us in the future, please fill out the form below. The information you provide will only be used by Janssen Biotech, Inc. At any time, you may unsubscribe to this opt-in list. See the below Information Collection Terms for details.

For patients, caregivers, or healthcare professionals

If you would like to receive more information about MCD and updates on SYLVANT® and MCD-related issues, please fill out the form below. The information you provide will only be used by Janssen Biotech, Inc. At any time, you may unsubscribe to this opt-in list. See the below Information Collection Terms for details. If you are a healthcare professional, please click here

*Indicates a required field.

Information collection terms

By providing your information above, you are requesting to receive more information about Multicentric Castleman’s Disease. Your information will be used to satisfy this purpose, and to fulfill any optional requests you may have indicated.

At any time, you can request to be removed from our contact list by clicking here. All information you provide above will be governed by our Privacy Policy. By providing us your information and clicking on the below SUBMIT button, you have read, understand, and agree to these terms.

resources

Resource Downloads

For your convenience, here are downloadable resources for both you and your patients regarding treatment with SYLVANT® (siltuximab).